195 related articles for article (PubMed ID: 35136158)
21. Menaquinone-7 as a novel pharmacological therapy in the treatment of rheumatoid arthritis: A clinical study.
Abdel-Rahman MS; Alkady EA; Ahmed S
Eur J Pharmacol; 2015 Aug; 761():273-8. PubMed ID: 26073022
[TBL] [Abstract][Full Text] [Related]
22. Blood monocyte chemotactic protein-1 (MCP-1) and adapted disease activity Score28-MCP-1: favorable indicators for rheumatoid arthritis activity.
Liou LB; Tsai WP; Chang CJ; Chao WJ; Chen MH
PLoS One; 2013; 8(1):e55346. PubMed ID: 23383162
[TBL] [Abstract][Full Text] [Related]
23. Serum vitamin D level and disease activity in patients with recent onset rheumatoid arthritis.
Zakeri Z; Sandoughi M; Mashhadi MA; Raeesi V; Shahbakhsh S
Int J Rheum Dis; 2016 Apr; 19(4):343-7. PubMed ID: 24134402
[TBL] [Abstract][Full Text] [Related]
24. Circulating adiponectin and visfatin levels in rheumatoid arthritis and their correlation with disease activity: A meta-analysis.
Lee YH; Bae SC
Int J Rheum Dis; 2018 Mar; 21(3):664-672. PubMed ID: 28205390
[TBL] [Abstract][Full Text] [Related]
25. Increased myeloperoxidase plasma levels in rheumatoid arthritis.
Fernandes RM; da Silva NP; Sato EI
Rheumatol Int; 2012 Jun; 32(6):1605-9. PubMed ID: 21331575
[TBL] [Abstract][Full Text] [Related]
26. Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis.
Hammer HB; Odegard S; Fagerhol MK; Landewé R; van der Heijde D; Uhlig T; Mowinckel P; Kvien TK
Ann Rheum Dis; 2007 Aug; 66(8):1093-7. PubMed ID: 17234650
[TBL] [Abstract][Full Text] [Related]
27. Prospective Comparison of Angiogenesis-Specific 68Ga-RGD2 PET/CT Imaging Parameters and DAS28-ESR in Rheumatoid Arthritis.
Kavanal AJ; Bhattacharya A; Sharma A; Shukla J; Chattopadhyay A; M B A; Sharma V; Vatsa R; Rana N; Kaur G; Mittal BR
Clin Nucl Med; 2021 Jul; 46(7):556-561. PubMed ID: 33782288
[TBL] [Abstract][Full Text] [Related]
28. Correlation of rheumatoid arthritis activity indexes (Disease Activity Score 28 measured with ESR and CRP, Simplified Disease Activity Index and Clinical Disease Activity Index) and agreement of disease activity states with various cut-off points in a Northeastern Brazilian population.
Medeiros MM; de Oliveira BM; de Cerqueira JV; Quixadá RT; de Oliveira ÍM
Rev Bras Reumatol; 2015; 55(6):477-84. PubMed ID: 25772662
[TBL] [Abstract][Full Text] [Related]
29. Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis.
Giles JT; Allison M; Bingham CO; Scott WM; Bathon JM
Arthritis Rheum; 2009 Sep; 61(9):1248-56. PubMed ID: 19714593
[TBL] [Abstract][Full Text] [Related]
30. Infliximab equivalently suppresses oxidative stress compared to tocilizumab among well-controlled patients with rheumatoid arthritis.
Kizaki K; Yamashita F; Hayashi T; Funakoshi N
Int J Rheum Dis; 2018 Oct; 21(10):1815-1821. PubMed ID: 27778459
[TBL] [Abstract][Full Text] [Related]
31. Gender stratified adjustment of the DAS28-CRP improves inter-score agreement with the DAS28-ESR in rheumatoid arthritis.
Hamann PDH; Shaddick G; Hyrich K; Green A; McHugh N; Pauling JD;
Rheumatology (Oxford); 2019 May; 58(5):831-835. PubMed ID: 30590784
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the DAS28-CRP and DAS28-ESR in patients with rheumatoid arthritis.
Sengul I; Akcay-Yalbuzdag S; Ince B; Goksel-Karatepe A; Kaya T
Int J Rheum Dis; 2015 Jul; 18(6):640-5. PubMed ID: 26013310
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Serum Calprotectin Level and Disease Activity in Patients with Rheumatoid Arthritis.
Aghdashi MA; Seyedmardani S; Ghasemi S; Khodamoradi Z
Curr Rheumatol Rev; 2019; 15(4):316-320. PubMed ID: 30666913
[TBL] [Abstract][Full Text] [Related]
34. The comparative responsiveness of the patient self-report questionnaires and composite disease indices for assessing rheumatoid arthritis activity in routine care.
Salaffi F; Ciapetti A; Gasparini S; Carotti M; Bombardieri S;
Clin Exp Rheumatol; 2012; 30(6):912-21. PubMed ID: 22935335
[TBL] [Abstract][Full Text] [Related]
35. Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial.
Hambardzumyan K; Bolce R; Saevarsdottir S; Cruickshank SE; Sasso EH; Chernoff D; Forslind K; Petersson IF; Geborek P; van Vollenhoven RF
Ann Rheum Dis; 2015 Jun; 74(6):1102-9. PubMed ID: 24812287
[TBL] [Abstract][Full Text] [Related]
36. [Serum and synovial adiponectin, resistin, and visfatin levels in rheumatoid arthritis patients. Relation to disease activity].
Alkady EA; Ahmed HM; Tag L; Abdou MA
Z Rheumatol; 2011 Sep; 70(7):602-8. PubMed ID: 21789720
[TBL] [Abstract][Full Text] [Related]
37. The relationships of CD8+ T cell subsets in RA patients with disease activity and clinical parameters.
He J; Li Y; Chen J; Wu Q; Shan H; Wang X; Zhang M; Nie L; Wang Q
Int Immunopharmacol; 2023 Jan; 114():109399. PubMed ID: 36442285
[TBL] [Abstract][Full Text] [Related]
38. Association between Rheumatoid Arthritis Disease Activity and Risk of Ovarian Malignancy in Middle-Aged and Elderly Women.
Huang Z; Tan L; Ling Y; Huang F; Ma W
Biomed Res Int; 2022; 2022():1062703. PubMed ID: 35663045
[TBL] [Abstract][Full Text] [Related]
39. α-2,3-Sialyltransferase 1 and neuraminidase-3 from monocytes in patients with rheumatoid arthritis correlate with disease activity measures: A pilot study.
Liou LB; Jang SS
J Chin Med Assoc; 2019 Mar; 82(3):179-185. PubMed ID: 30913115
[TBL] [Abstract][Full Text] [Related]
40. Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial.
Dale J; Stirling A; Zhang R; Purves D; Foley J; Sambrook M; Conaghan PG; van der Heijde D; McConnachie A; McInnes IB; Porter D
Ann Rheum Dis; 2016 Jun; 75(6):1043-50. PubMed ID: 27026689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
